During the past decade, Charité Campus Virchow Klinikum-Medizinische Klinik mit Schwerpunkt Kardiologie conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Charité Campus Virchow Klinikum-Medizinische Klinik mit Schwerpunkt Kardiologie" #1 sponsor was "University Hospital, Saarland" with 3 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "ACS Biomarker" with 1 trials sponsored, "BioControl Medical" with 1 trials sponsored and "Charite University, Berlin, Germany" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Charité Campus Virchow Klinikum-Medizinische Klinik mit Schwerpunkt Kardiologie" #1 collaborator was "B.Braun Vascular Systems, Berlin, Germany" with 1 trials as a collaborator, "Brahms AG" with 1 trials as a collaborator, "Clinical Trial Unit, University Hospital Basel, Switzerland" with 1 trials as a collaborator, "Institut National de la Santé Et de la Recherche Médicale, France" with 1 trials as a collaborator and "London School of Hygiene and Tropical Medicine" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Charité Campus Virchow Klinikum-Medizinische Klinik mit Schwerpunkt Kardiologie" are "Coronary Restenosis" (2 trials), "Heart Failure" (2 trials), "Atrial Fibrillation" (1 trials), "Coronary Artery Disease" (1 trials) and "Coronary Heart Disease" (1 trials). Many other conditions were trialed in "Charité Campus Virchow Klinikum-Medizinische Klinik mit Schwerpunkt Kardiologie" in a lesser frequency.

Most popular intervention types in "Charité Campus Virchow Klinikum-Medizinische Klinik mit Schwerpunkt Kardiologie" are "Device" (5 trials), "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "paclitaxel coated balloon catheter (device with drug)" (2 trials), "Alectinib" (1 trials), "CardioFit® System" (1 trials), "Clopidogrel" (1 trials) and "DEBlue stent vs. Cypher stent" (1 trials). Other intervention names were less common.

The vast majority of trials in "Charité Campus Virchow Klinikum-Medizinische Klinik mit Schwerpunkt Kardiologie" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Charité Campus Virchow Klinikum-Medizinische Klinik mit Schwerpunkt Kardiologie". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Charité Campus Virchow Klinikum-Medizinische Klinik mit Schwerpunkt Kardiologie, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Charité Campus Virchow Klinikum-Medizinische Klinik mit Schwerpunkt Kardiologie, 4 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".